Recent studies indicated that HDAC activity is also associated with the development and progression of some chronic diseases characterized by fibrosis [48], including chronic kidney disease, cardiac hypertrophy, and idiopathic pulmonary fibrosis and was suggested as a potential target for the treatment of fibrosis [12]. The gene discussed is HDAC9; the disease is chronic kidney disease.